These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24481566)

  • 1. Neuroprotection by the synthetic neurosteroid enantiomers ent-PREGS and ent-DHEAS against Aβ₂₅₋₃₅ peptide-induced toxicity in vitro and in vivo in mice.
    El Bitar F; Meunier J; Villard V; Alméras M; Krishnan K; Covey DF; Maurice T; Akwa Y
    Psychopharmacology (Berl); 2014 Sep; 231(17):3293-3312. PubMed ID: 24481566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection.
    Yang R; Chen L; Wang H; Xu B; Tomimoto H; Chen L
    Neuropharmacology; 2012 Nov; 63(6):1042-50. PubMed ID: 22884465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.
    Meunier J; Ieni J; Maurice T
    Br J Pharmacol; 2006 Dec; 149(8):998-1012. PubMed ID: 17057756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease.
    Carles A; Hoffmann M; Scheiner M; Crouzier L; Bertrand-Gaday C; Chatonnet A; Decker M; Maurice T
    CNS Neurosci Ther; 2024 Jun; 30(6):e14814. PubMed ID: 38887858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid structure and pharmacological properties determine the anti-amnesic effects of pregnenolone sulphate in the passive avoidance task in rats.
    Vallée M; Shen W; Heinrichs SC; Zorumski CF; Covey DF; Koob GF; Purdy RH
    Eur J Neurosci; 2001 Dec; 14(12):2003-10. PubMed ID: 11860495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice.
    Naert G; Ferré V; Meunier J; Keller E; Malmström S; Givalois L; Carreaux F; Bazureau JP; Maurice T
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2170-82. PubMed ID: 26381812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
    Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
    J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral steroid sulfatase inhibition potentiates improvement of memory retention for hippocampally administered dehydroepiandrosterone sulfate but not pregnenolone sulfate.
    Flood JF; Farr SA; Johnson DA; Li PK; Morley JE
    Psychoneuroendocrinology; 1999 Nov; 24(8):799-811. PubMed ID: 10581651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease.
    Couly S; Denus M; Bouchet M; Rubinstenn G; Maurice T
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):142-157. PubMed ID: 32977336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sigma(1) receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats.
    Zou LB; Yamada K; Sasa M; Nakata Y; Nabeshima T
    Neuropharmacology; 2000 Jul; 39(9):1617-27. PubMed ID: 10854906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients.
    Weill-Engerer S; David JP; Sazdovitch V; Liere P; Eychenne B; Pianos A; Schumacher M; Delacourte A; Baulieu EE; Akwa Y
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5138-43. PubMed ID: 12414884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer's disease.
    Lee YW; Kim DH; Jeon SJ; Park SJ; Kim JM; Jung JM; Lee HE; Bae SG; Oh HK; Son KH; Ryu JH
    Eur J Pharmacol; 2013 Mar; 704(1-3):70-7. PubMed ID: 23461850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine exerts neuroprotective effects against β-amyloid-induced neurotoxicity in SH-SY5Y cells through the Erk1/2-p38-JNK-dependent signaling pathway.
    Xue MQ; Liu XX; Zhang YL; Gao FG
    Int J Mol Med; 2014 Apr; 33(4):925-33. PubMed ID: 24481039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice.
    Villard V; Espallergues J; Keller E; Alkam T; Nitta A; Yamada K; Nabeshima T; Vamvakides A; Maurice T
    Neuropsychopharmacology; 2009 May; 34(6):1552-66. PubMed ID: 19052542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors.
    Urani A; Privat A; Maurice T
    Brain Res; 1998 Jul; 799(1):64-77. PubMed ID: 9666079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism.
    Maurice T; Su TP; Privat A
    Neuroscience; 1998 Mar; 83(2):413-28. PubMed ID: 9460750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 22R-Hydroxycholesterol protects neuronal cells from beta-amyloid-induced cytotoxicity by binding to beta-amyloid peptide.
    Yao ZX; Brown RC; Teper G; Greeson J; Papadopoulos V
    J Neurochem; 2002 Dec; 83(5):1110-9. PubMed ID: 12437582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A post-training intrahippocampal anxiogenic dose of the neurosteroid pregnenolone sulfate impairs passive avoidance retention.
    Martín-García E; Pallarés M
    Exp Brain Res; 2008 Nov; 191(2):123-31. PubMed ID: 18665356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ
    Ji Y; Hu Y; Ren J; Khanna R; Yao Y; Chen Y; Li Q; Sun L
    Chem Biol Interact; 2019 May; 305():28-39. PubMed ID: 30871964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosteroids enhance the viability of staurosporine and doxorubicin treated differentiated human neuroblastoma SH-SY5Y cells.
    Leśkiewicz M; Regulska M; Budziszewska B; Jantas D; Jaworska-Feil L; Basta-Kaim A; Kubera M; Lasoń W
    Pharmacol Rep; 2008; 60(5):685-91. PubMed ID: 19066415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.